Global Folinic Acid Market Overview:
Folinic acid also known as leucovorin or calcium folinate, helps in the chemotherapy treatment to make the chemotherapy work better and reduce side effects. It can be given to the patients into a vein by injection or can be taken as a pill. It is used in hospitals, clinics, and other medical centers, it increases the effect of another treatment helping the patient to recover faster. The increasing cancer patients across the world along with rise in rheumatoid arthritis disease has been driving the global folinic acid. However, the stringent regulatory guidelines and side effects associated with folinic acid might hamper the growth of the global market.
As per latest study released by AMA Research, the Global Folinic Acid market is expected to see growth rate of 5.5%Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Forecast Period | 2024-2030 |
Historical Period | 2018-2023 |
Unit | Value (USD Million) |
Customization Scope | Avail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility |
Influencing Trend:
Continuous Research and Development of Folinic Acid and The emerging use of Folinic Acid in Food Supplements
Market Growth Drivers:
Growing Number of Cancer Patient and Rising Rheumatoid Arthritis in Old Age People
Restraints:
Side Effects Associated with the Use of Folinic Acid Might be the Hindrance for the Market and Stringent Regulatory Guidelines Regarding the Use of Folinic Acid
Opportunities:
Surging Demand for Folinic Acid from Research Laboratories and Growing Healthcare Sector
Competitive Landscape:
Key players are adopting numerous strategies to gain market attention and to increase their market share, this strategy can be listed as increasing product portfolio, making partnerships to adopt certain technologies, and acquiring small players to finish the competition in the future. As well as investing money in the R&D sector to make technical upgrades to the product.
Some of the key players profiled in the report are PMC Group Inc. (United States), Clinigen Group plc (United Kingdom), Pfizer Inc. (Canada), National Vitamin Co Inc. (United States), NOW Foods (United States), Solgar Inc. (United States), Nature's Bounty Co. (United States), Sundown Naturals (Canada), Nutraceutical Corporation (United States) and Wyeth Ayerst Canada Inc. (Canada). Additionally, following companies can also be profiled that are part of our coverage like Teva Parenteral Medicines Inc. (United States). Considering Market by Form, the sub-segment i.e. Tablets will boost the Folinic Acid market. Considering Market by Distribution Channels, the sub-segment i.e. Online will boost the Folinic Acid market.
Latest Market Insights:
In July 2022, Merck entered into a supply agreement with Teva Pharmaceutical Industries for the commercialization of Teva's Leucovorin injection (Folinic Acid), expanding access to the product in the United States.
In October 2022, Dr. Reddy's Laboratories launched Folinic Acid Injection USP 15mg/ml in the US market, further expanding the available options.
"The European product, known as Calcium Folinate Solution for Injection, has not previously been reviewed or approved by the FDA but is of the same qualitative formulation as Leucovorin Calcium for Injection previously approved for marketing in the U.S. when the latter is reconstituted with water. Calcium Folinate Solution for Injection is manufactured in accord with European Good Manufacturing Practice regulations at our site in Godollo, Hungary and marketed through our Teva UK affiliate."
What Can be Explored with the Folinic Acid Market Study
Gain Market Understanding
Identify Growth Opportunities
Analyze and Measure the Global Folinic Acid Market by Identifying Investment across various Industry Verticals
Understand the Trends that will drive Future Changes in Folinic Acid
Understand the Competitive Scenario
- Track Right Markets
- Identify the Right Verticals
Research Methodology:
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Folinic Acid market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Folinic Acid market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Folinic Acid Manufacturers, Folinic Acid International Traders, Folinic Acid Distributors and Suppliers, Research and Development Institutes, Regulatory Bodies, Potential Investors, Industry Associations, Upstream and Downstream Buyers and Others.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.